Treatment of staphylococcus infections using transgenic expression of a modified lysostaphin gene

Details for Australian Patent Application No. 2003225613 (hide)

Owner UNIVERSITY OF VERMONT

Inventors Kerr, David; Plaut, Karen, I.; Bramley, John, A.

Agent Davies Collison Cave

Pub. Number AU-A-2003225613

PCT Number PCT/US03/06036

PCT Pub. Number WO2003/074689

Priority 10/087,667 28.02.02 US

Filing date 28 February 2003

Wipo publication date 16 September 2003

International Classifications

C12N 009/52 Enzymes, e.g. ligases (6.) - derived from bacteria

A01K 067/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 10/087,667 28.02.02 US

23 October 2003 Application Open to Public Inspection

  Published as AU-A-2003225613

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003225614-PORTABLE BATTERY OPERATED ASPIRATOR

2003225612-EXPRESSION OF HIV-RELATED PROTEINS IN PLANTS